These seemingly contradictory effects of CB1‐mediated cannabinoid signaling may be explained by the fact that the effect of cannabinoids in the regulation of anxiety and fear depends on the dose, the duration of the treatment and the preexisting conditions of the subject (Maldonado et al., 2020). This evidence concerns the gene CNR1 and Anxiety.